Evidence map›Paper›PMID 32165689›Full record

ArticleScientific reports2020

Publisher Correction: The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.

Julia Castello, Marisol Cortés, Lauren Malave, Andreas Kottmann, David R Sibley, Eitan Friedman, Heike Rebholz

Open access · goldAbstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Julia Castello *Department of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.
Marisol Cortés *Department of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.
Lauren MalaveDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.
Andreas KottmannDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-5435-7502
David R SibleyMolecular Neuropharmacology Section, National Institute of Neurologic Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA.
Eitan FriedmanDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA.
Heike RebholzDepartment of Molecular, Cellular & Biomedical Sciences, CUNY School of Medicine, New York, NY, USA. heikerebholz@gmail.com.
The Graduate Center, CUNY · USCUNY School of Law · USDanube Private University · ATNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32165689
PMCPMC7067756
OpenAlexW3011612253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.